A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

Early detection of lung cancer can drastically improve survival rates. Sponsored by Virginia Mason Franciscan Health.

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...

Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...

Living with lung cancer often means spending more time in waiting rooms than in the moments that matter. But that could ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

A recent analysis reveals that monthly prices of checkpoint inhibitors decreased only a small amount over a decade.

The collaboration brings Qure.ai’s lung cancer detection and management tools to hospitals and health systems across the USA ...

Qure.ai and Microsoft to deploy lung cancer AI on Precision Imaging Network, aiming to speed early detection and simplify ...

Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...